Game Changers Radicalization of ART tools and delivery New ways to manage IP: aggressive use of TRIPS flex and effective patent pool Financial transaction.

Slides:



Advertisements
Similar presentations
TIERED PRICES (or Differentiated Prices or Market Segmentation) What is it ? A strategic use of price differentiation based on customers wealth (irrespective.
Advertisements

The de-linkage of the cost of research and development and the price of health products Michelle Childs Director Policy Advocacy.
Intellectual Property Rights, Investment and Transfer of Technology in the Pharmaceutical Sector Patrizia Carlevaro Head of the International Aid Unit.
DEVELOPING COUNTRIES AND IP: ACCESS TO HEALTH CARE EDUCATION MATERIALS Karen A. LeCuyer, Ph.D. University of Connecticut School of Law 30 May 2007.
Differential pricing and access to medicines: issues and options Andrew Creese Essential Drugs and Medicines Policy Health Technology and Pharmaceuticals.
2 nd WIPO Inter-Regional Meeting on South- South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement Cairo.
Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.
Taking Another Look at Condoms Patrick Friel Reproductive Health HIV/AIDS Consultancy 27 April 2006.
UNITAID Innovative Financing Mechanism  Denis Broun Executive Director.
Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni, Secretary General Interpharma.
Benjamin Blasco Anna Ferretti Sophie Venet BIO615 Fall 2009.
The role of commercial enterprises in health Dr. Petra Laux, GSK Brussels September 2001.
“Using Competition Law to Promote Access to Health Technologies” Access to Innovation: Making Generic Versions of Newer ARVs Affordable 24 July 2014 Melbourne,
Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
1 ICC and AIPLA Paris, September 13, 2002 Felix Addor Chief Legal Officer and Deputy Director General Swiss Federal Institute of Intellectual Property.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
A very short introduction to patents & access to medicines.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.
Community Views on Intellectual Property as a Barrier to Access UNITAID Meeting – 4th OCT Sarah Zaidi, International Treatment Preparedness Coalition.
Hong Kong Agreement on IPR and Access to Medicines: Public Health & Human Rights Considerations J. Craig Phillips LLM, MSN, ARNP, BC, ACRN Florida International.
GLOBAL SOURCING & MANUFACTURING LOGISTICS: Superimposing Complexities
Public health, innovation and intellectual property 1 |1 | Dr Germán Velásquez Director WHO Secretariat Public Health, Innovation and Intellectual Property.
Access to medicines, WTO TRIPS and Seychelles patent law Ellen ‘t Hoen, Medicines Law & Policy Seychelles September 2014.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
UK Policy considerations on increasing access to medicines for the poor in developing countries. DEPARTMENT FOR INTERNATIONAL DEVELOPMENT.
 .
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
ZOU Ji, Professor School of Environment and Natural Resources Innovative Mechanism for Development and Transfer of ESTs: China’s Perspectives ICTSD Geneva.
1 Stop Stock-outs! Access to Medicines for All! anti-counterfeiting initiatives and other access barriers Christa Cepuch OSI AEM Initiative – CS Role and.
Options for national/regional production of generic medicines Wilbert Bannenberg, MD MPH Lesotho TRIPS workshop 14 Aug 2014.
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
Getting the best treatment to the most people possible Enabling policies: threats & opportunities MSF Access Campaign.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Matthew Kavanagh Fighting AIDS in a Financial Crisis: We Can Do Better, More, Faster.
1 |1 | Treatment 2.0 Catalyzing the Next Phase of Scale-up Gottfried Hirnschall Director, HIV Department WHO, Geneva.
Do Patents Make HIV/AIDS Medication Inaccessible to Patients in Sub-Saharan Africa? Abstract There has been debate surrounding the issue of patents and.
ACCESS TO MEDICINES - POLICY AND ISSUES
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
Intellectual Property Rights and Pharmaceuticals (Following Up the ‘Novartis case’ ) Background note prepared for PHM Vic Internet Workshop.
PATENT POOL & its CONCERNS PATENT POOL & its CONCERNS Manmohan A Amonkar 20 July 2010.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
Stop the Stock-outs! Access to Essential Medicines for All Christa Cepuch BSc Phm Health Action International Africa RHS Coalition Meeting 27 May 2010,
Ellen ‘t Hoen Médecins sans Frontières
Preliminary classification of proposals by the CEWG Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative Expert Working.
Access to Medicines Making Innovation work for the poor Corinna Heineke Diversity in Innovation European Patent Conference, Brussels, 15/16 May 2007.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
Uniting Forces for Access to Hepatitis C Treatment Global Epidemiology Global Epidemiology & Treatment Access Issues & Treatment Access Issues Tracy Swan.
Strategies to increase access to high priced medicines and vaccines: lessons, new challenges and opportunities Judit Rius Sanjuan U.S. Manager & Legal.
TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.
Access to medicines challenges in Europe: What is wrong and the way forward Presented by: Rohit Malpani Director of Policy & Analysis, Access Campaign.
Intellectual Property - Patents, Copyrights, and Other Protectionist Barriers CEPR Basic Economics Seminar Dean Baker November 17, 2005.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
Malebona Precious Matsoso Director General: Health 22 July 2016 AIDS 2016 CONFERENCE Essential Medicines, Intellectual Property and Access.
Patents & Public Health
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
How Advocacy can Influence Pricing & Policy
Intellectual Property Protection and Access to Medicines
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
Carnegie Institution of Washington
Charting a new course for HIV and health in Africa:
Treat the world: Working united across diseases for quality and affordable treatment for all – AIDS 2018 TRIPS Flexibilities 0.2 Across Diseases Ellen.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Presentation transcript:

Game Changers Radicalization of ART tools and delivery New ways to manage IP: aggressive use of TRIPS flex and effective patent pool Financial transaction tax: tax and treat

Radicalization of ART tools: Point of Care Diagnostics CD4: Affordable point of care tests are on the horizon for One stop test package: HIV test + CD4 Viral load: – Essential to detection of treatment failure – Several projects for development of point of care VL but progress slow. High priority

Game changer: New ways to manage intellectual property Make the Medicines Licensing Pool work Companies to provide licenses at the right terms Full use of TRIPS flexibilities Strict patentability criteria, patent opposition, use of compulsory license and others No TRIPS+ and increased IP enforcement No free trade agreements or anti-counterfeit legislations/agreements that harm access to medicines Generic competition proven to be more efficient than differential pricing

Game Changer: Additional funding for health – tax and treat Pre-condition: – Donor commitments to replenish the Global Fund - > US$ 20 billion needed for Financial Transaction Tax – A small tax to raise the additional resources to fund the health related Millenium Development Goals – For example: currency transaction tax. Can be started between any two or more currencies – Politically and technically feasible. – Next key dates: MDG summit in New York in September, G20 in Korea in November